Hot Stocks

The stock market changes from minute to minute, and what’s hot today may not be hot tomorrow. Our expert analysts spot hot stocks that are heating up before the crowd swoops in to bid prices higher, and our journalists sift through the noise to shine a light on trending investments -- in spaces ranging from quantum computing to marijuana stocks -- to determine whether they’re actually worth your time.

Pepsi, Gatorade Want to Dominate $20B Sports Nutrition Market

By Jeff Reeves
Gatorade is planning to vastly expand its offerings in the sports nutrition market. However, parent PepsiCo has a history of botched rebrandings.

Best and Worst Stocks After the Black Friday Sales Surge

By Jeff Reeves
Consumers opened their wallets much wider than in 2010, but some companies capitalized better than others.

Merck CEO Pledges Drug Pipeline Will Yield Results in Both Short and Long Term

By Barry Cohen, Health Care Writer
Merck CEO Kenneth Frazier acknowledges company's lagging stock, touts potential of numerous drugs in late development stages.

Is It Time to Call the Bottom in Solar Stocks?

By Jim Woods, Editor-in-Chief, Successful Investing, Intelligence Report, Bullseye Stock Trader
Solar stocks have plunged all year, but one famed analyst believes the sector will shine again. Here's why and when.

Why Buffett’s IBM Buy Is a Sell Signal for Tech Stocks

By Jamie Dlugosch, InvestorPlace Writer
If legendary value investor Warren Buffett is changing his stripes, it's trouble. Chances are he's finally making a move into tech after it's too late.

Not All Food Stocks Are Created Equal

By Will Ashworth, InvestorPlace Contributor
Food stocks traditionally are considered a sure-fire hedge against inflation. But investors should take a closer look at these nuances before blindly buying.

What to Watch for in Agriculture Investing

By Daniel Putnam, InvestorPlace Contributor
Fertilizer stocks have been hit hard lately. That could change, especially if upbeat farm forecasts from the likes of Deere pan out.

Gold, Silver Heading South for Thanksgiving

By Andrew Burger, InvestorPlace Contributor
Gold was slipping and silver plummeting Wednesday morning. Especially hit hard were miners, including NovaGold Resources and Hecla Mining.

Pfizer’s Latest Gambit for Keeping Lipitor Alive

By Barry Cohen, Health Care Writer
Like a vampire refusing to die, Lipitor keeps on going. Now, PFE has a deal to sell the cholesterol-lowering drug directly to patients at generic cost.

5 ‘New Frugal’ Black Friday Stocks

By Michael Shulman, Editor, Options Income Blueprint
On Black Friday, consumers will embrace a new mind-set when they shop at these primarily upscale brands. Investors should follow them through the doors.

American’s Fall Could Make Boeing Falter

By Susan J. Aluise, Aviation, Auto & Transportation Writer
Boeing's recent plane order from AMR Corp. is looking shakier, and the sweet financing Boeing had to offer AMR could come back to haunt it.

Netflix, Groupon Bomb — Tuesday’s IP Market Recap

By Kyle Woodley, Senior Investing Editor, Kiplinger
Netflix (NFLX) shares give up more than 5% Tuesday, and Groupon (GRPN) drops near its IPO valuation.

For Value Investors, It’s IBM — Not HP

By Will Ashworth, InvestorPlace Contributor
Hewlett-Packard just came off bad earnings and is down 53% below its five-year high. HPQ might scream value, but bellwether IBM is screaming louder.

Volatility High as Gold, Silver Recover from Monday’s Plunge

By Andrew Burger, InvestorPlace Contributor
Gold and silver prices headed higher Tuesday morning, with NovaGold Resources (NG) and other gold miners enjoying boosts. Silver miners fell against the grain.

St. Jude or Medtronic: Which Is Healthier for Your Portfolio?

By Peter Cohan, InvestorPlace Writer
STJ and MDT are thriving in a tough industry -- cardiovascular rhythm management -- but one may have an edge.

Netflix Scrambles for Cash to Buy New Shows

By Jeff Reeves
Netflix can't buy new shows without cash, and can't win over investors without new content.

Supercommittee Skunks Wall Street — Monday’s IP Market Recap

By Kyle Woodley, Senior Investing Editor, Kiplinger
The congressional supercommittee's failure to reach a debt resolution sends the Dow down 250 points. RIM, Sony among companies reaching 52-week lows.

Gilead’s Giant Gamble in Buying Pharmasset

By Barry Cohen, Health Care Writer
The $11B price tag raises the stakes big-time, and critics say Gilead is overpaying to get Pharmasset's promising hepatitis C treatment.

Ross Stores — 3 Pros, 3 Cons

By Tom Taulli, InvestorPlace Contributor
Discount retailer Ross Stores posted solid quarterly results, but is ROST stock a good investment in such a high-competition sector?
Load More Articles